Business

New open access journal npj Vaccines announced by Nature Publishing Group and The University of Texas Medical Branch

New open access journal npj Vaccines announced by Nature Publishing Group and The University of Texas Medical Branch

2 Minute Read

Nature Publishing Group and The University of Texas Medical Branch at Galveston on behalf of its Sealy Center for Vaccine Development announce the launch of a new open access journal called npj Vaccines. The new journal will be dedicated to highlighting the most important scientific advances in vaccine research and development.

Editor-in-Chief Alan D. Barrett, director of UTMB’s Sealy Center for Vaccine Development said, “We’re very excited to partner with Nature and together we plan on publishing significant new advances in vaccine research and development. One of our main goals is to share information that will help researchers who are looking for state-of-the-art research about vaccines. We want to become a prime source of up-to-date information about vaccine development and how vaccines are helping to improve our lives and saving the lives of millions of people around the globe.

Dr. Danny O. Jacobs, UTMB executive vice president and provost, and dean of the School of Medicine said, “I share Barrett’s enthusiasm and excitement about our new partnership with Nature Publishing Group in recognition of our organizations’ mutual interests and collective expertise. Without a doubt, there is a clear need for a high impact open access journal that focuses on identifying and reporting the most important and significant information on vaccines to control infectious diseases and non-infectious disease in the future.”

Martin Delahunty, Global Head of Partnership Journals at Nature Publishing Group said, “We want to encourage decision-making about vaccines on the basis of up-to-date scientific research and evidence. The articles from npj Vaccines will be open access and therefore free to read at the point of publication. They can be read and shared by anyone across the globe, from scientific researchers to clinicians working in remote areas and parents looking for the latest research on vaccinations.”

The journal will publish a variety of research articles on human and veterinary vaccinations from discovery and basic science to nonclinical development of vaccines, vaccine formulation, AIDS vaccine development, cancer/oncology vaccines, clinical evaluation of vaccines and vaccine safety, to mention just a few.

Each original research article will include a lay summary that will summarize the key issues being addressed within the article with the goal of keeping the readership informed of advances in the field of vaccinology.

Given the public health importance of vaccines, in addition to publishing high quality original research, npj Vaccines also publishes commentaries, news, research highlights, editorials and correspondence from readers, to provide state-of-the-art information for all of those interested in vaccines.

The website for npj Vaccines can be found here and more information on the Nature Partner Journal program can be found here.

Back to top